OpenBiome Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OpenBiome's estimated annual revenue is currently $5.1M per year.(i)
  • OpenBiome's estimated revenue per employee is $155,000

Employee Data

  • OpenBiome has 33 Employees.(i)
  • OpenBiome grew their employee count by -3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$7M4573%N/AN/A
#10
$5.4M353%N/AN/A
Add Company

OpenBiome's mission is to expand access to fecal microbiota transplantations (FMT) and help lead groundbreaking research into the human microbiome. We care deeply about helping patients. We get excited about poop. We are passionate individuals who get up in the morning to help our clinical partners and strive to be at the cutting edge of a new field of medical science that we are helping to build.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

N/A

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OpenBiome's People

NameTitleEmail/Phone
1
Human Capital ManagerReveal Email/Phone
2
Co-founder and AdvisorReveal Email/Phone
3
Accounting ManagerReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
Regulatory Affairs ManagerReveal Email/Phone
6
Site SupervisorReveal Email/Phone
7
Manufacturing Technician IIReveal Email/Phone
8
Quality Assurance AssociateReveal Email/Phone
9
Manager Legal AffairsReveal Email/Phone
10
Director Clinical OutreachReveal Email/Phone

OpenBiome News

2022-04-17 - Finch Therapeutics to shed 20% of its workforce

In January 2021, Finch's then-contract manufacturer, OpenBiome, was released from clinical hold after implementing a direct testing method for...

2022-04-17 - Fitch Therapeutics to shed 20% of its workforce

At that time, the FDA placed Finch's IND for CP101 and the IND of its then-contract manufacturer, OpenBiome, on partial clinical hold,...

2021-02-23 - OpenBiome to wind down stool bank operations

OpenBiome, the nation’s first public stool bank, will soon end its program for collecting, screening, and shipping material for fecal microbiota transplants, or FMT, the company announced Tuesday. It won’t be immediate; the company plans to resume shipping the stool it has in its inventory to p ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M33N/AN/A
#2
N/A333%N/A
#3
$8.5M333%N/A
#4
$2.7M33-8%N/A
#5
$3.7M330%N/A